At Tuesday’s closing price, Mankind Pharma was valued at a price-to-earnings ratio of 43 times its FY22 earnings. Mankind is now India’s fifth largest pharma company by market value of ₹57,046 crore. Sun Pharma, Divi’s Lab, Dr. Reddy’s Lab, and Cipla are currently valued between ₹75,284 crore and ₹2.31 lakh crore.
Kotak Mahindra MF, Citigroup, others buy 10.64% stake in Home First Finance for Rs 1,307 crore
Kotak Mahindra MF, Fidelity, Morgan Stanley, and Citigroup Global Markets Mauritius are among those entities that collectively bought a 10.64 per cent stake in Home